Machine Learning Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19… AIT News Desk May 27, 2022 Insilico's candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for…